The global menopause market size was estimated at USD 17.79 billion in 2024 and is projected to reach USD 24.35 billion by 2030, growing at a CAGR of 5.42% from 2025 to 2030. The market’s growth is largely driven by demographic changes, a rising aging female population, and increasing awareness of the health and wellness needs specific to women undergoing menopause.

By 2025, over 1 billion women globally are expected to reach menopause, representing approximately 12% of the global population. Among these women, Vasomotor Symptoms (VMS), including hot flashes and night sweats, are reported by nearly 75%. According to a menopause study published by StatPearls Publishing LLC in December 2023, around 1.3 million women aged 51–52 in the U.S. experience menopause annually. Additionally, approximately 5% of women aged 40–45 experience early menopause symptoms, while 1% report premature menopause before the age of 40.

These symptoms can significantly affect quality of life and productivity, highlighting the importance of effective treatments. Consequently, there is a broad market for menopause-focused products, such as dietary supplements and over-the-counter (OTC) medications, which help alleviate symptoms including hot flashes, night sweats, osteoporosis, and vaginal atrophy.

Early intervention and treatment are also expected to reduce the financial burden of healthcare. Women experiencing VMS contribute to a global healthcare expenditure burden of USD 660 million, while productivity loss adds another USD 150 million. Moreover, menopause is associated with an increased risk of other health conditions, such as declining musculoskeletal health and cardiovascular issues. Among the most common conditions accelerated by menopause are hypertension (75%), depression (10%), and osteoporosis (30%), further emphasizing the need for effective management and therapeutic solutions for this population.

Key Market Trends & Insights:

In 2024, North America dominated the global menopause industry, accounting for the largest revenue share of 37.40%. This leadership is supported by advanced healthcare infrastructure, high awareness of menopausal health issues, strong purchasing power, and widespread adoption of menopause-related treatments and products across the region.

Within North America, the U.S. held the largest share of the menopause industry, representing 83.51% in 2024. The country’s dominance is attributed to factors such as the large aging female population, early adoption of innovative healthcare solutions, extensive availability of treatment options, and strong research and development in menopause management.

By treatment type, the dietary supplements segment led the market in 2024, accounting for the largest revenue share of 94.23%. This segment’s prominence reflects the widespread consumer preference for natural, non-prescription options to manage menopause symptoms, including hot flashes, night sweats, osteoporosis, and vaginal atrophy. The high adoption of dietary supplements underscores their perceived safety, accessibility, and effectiveness in supporting overall health and well-being during menopause.

Order a free sample PDF of the Menopause Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 17.79 Billion

• 2030 Projected Market Size: USD 24.35 Billion

• CAGR (2025-2030): 5.42%

• North America: Largest market in 2024

• Latin America: Fastest growing market

Key Companies & Market Share Insights:

Key participants in the menopause industry are actively implementing strategic initiatives aimed at driving business growth and strengthening their market presence. These strategies include expanding product portfolios to offer a broader range of menopause-related solutions, forming partnerships and collaborations to leverage complementary expertise, pursuing mergers and acquisitions to enhance capabilities and market reach, and broadening their business footprint across new geographies. By adopting these approaches, companies aim to better address the evolving needs of women undergoing menopause while capturing a larger share of the growing global market.

Key Players

• Bayer AG

• Theramex

• AbbVie, Inc.

• Pure Encapsulations, LLC

• Dr. Reddy’s Laboratories Ltd.

• ReNew Life Holdings Corporation

• Padagis

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The menopause market is poised for steady growth, driven by demographic trends, increasing awareness, and a strong preference for dietary supplements over prescription therapies. Rising demand for natural, non-hormonal options, especially in developed markets, along with expanding innovation and better access to care, is fueling market expansion.